Souhaitez-vous accéder aux communiqués récents ?

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

CHICAGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking, the world’s first ecosystem for memory and thinking concerns announced today that they have entered into an exclusive agreement to use...

Selbyville, Delaware, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Breast cancer liquid biopsy market size reached USD 305.9 million in 2023 and is projected to expand at a robust CAGR of 22.6% from 2024 to...

Burning Rock Announces Results of 2024 Annual General Meeting

Burning Rock Reports Third Quarter 2024 Financial Results

Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform

NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China

GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...

Burning Rock Reports Second Quarter 2024 Financial Results